VolitionRx Ltd
VNRX
36 hedge funds and large institutions have $18.7M invested in VolitionRx Ltd in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 5 closing their positions.
0.03% less ownership
Funds ownership: 0.58% → 0.56% (-0.03%)
3% less capital invested
Capital invested by funds: $19.2M → $18.7M (-$493K)
8% less funds holding
Funds holding: 39 → 36 (-3)
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
60% less call options, than puts
Call options by funds: $105K | Put options by funds: $262K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
+$821K |
| 2 |
Barclays
London,
United Kingdom
|
+$90K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
+$26.9K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$21.8K |
| 5 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$20.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
E
Ergoteles
New York
|
-$403K |
| 2 |
Renaissance Technologies
New York
|
-$401K |
| 3 |
Morgan Stanley
New York
|
-$385K |
| 4 |
HF
HRT Financial
New York
|
-$203K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$92K |
VNRX Hedge Fund Activity: Q4 2021 in Review
36 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q4 2021, worth a combined $18.7M — down 2.6% from $19.2M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of VNRX and 3 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 7 added.
The largest buyer was Lagoda Investment Management, adding an estimated $821K. The largest seller was Ergoteles, cutting an estimated $403K.
- 36 institutional investors held VolitionRx Ltd (VNRX) as of Q4 2021, down from 39 in Q3 2021.
- Funds reported $18.7M of VolitionRx Ltd stock for Q4 2021, down 2.6% quarter-over-quarter.
- 3 funds opened new VolitionRx Ltd positions in Q4 2021 and 5 closed out, a net change of -2 holders.
- The largest VolitionRx Ltd buyer in Q4 2021 was Lagoda Investment Management, an estimated $821K added.
- The largest VolitionRx Ltd seller in Q4 2021 was Ergoteles, an estimated $403K sold.
Based on aggregated 13F filings for Q4 2021.